Macula Society 2023: Dr. Kim Presents Phase 2 SC Safety Belzupacap Sarotalocan Data

A Phase 2 Trial of Belzupacap Sarotalocan (AU-011): An Investigational Targeted Therapy for Choroidal Melanoma via Suprachoroidal Administration